We are truly honored to have been named finalists for the prestigious 2024 European Lifestars Awards in the Women-Led … [Read more...] about Our CEO, Agnès Arbat, has achieved second place in the prestigious 2024 European Lifestars Awards, under the “Women-Led Business of the Year” category.
OXOLIFE has reached the final stage of the European Accelerator program
Exciting News! We are thrilled to announce that OXOLIFE has reached the final stage of the European Accelerator … [Read more...] about OXOLIFE has reached the final stage of the European Accelerator program
Watch our CEO Agnès Arbat talk to OptimumTV about fantastic Phase 2 results for our lead product OXO-001 and our plans for future
Agnès Arbat, explained in our last interview more details on our innovative solution for the treatment of female … [Read more...] about Watch our CEO Agnès Arbat talk to OptimumTV about fantastic Phase 2 results for our lead product OXO-001 and our plans for future
Our CEO Agnès Arbat has successfully made the finalist roster for the prestigious 2024 European Lifestars Awards in the Women-Led Business of the Year category
Winner will be announced in London during LSX Investival showcase, the kick off to Jefferies week on November … [Read more...] about Our CEO Agnès Arbat has successfully made the finalist roster for the prestigious 2024 European Lifestars Awards in the Women-Led Business of the Year category
A pill for infertility: Oxolife’s non-hormonal oral drug raises embryo implantation rate, pregnancy rates and live birth rate in women undergoing IVF and ICSI, data being presented at ESHRE shows
A pill for infertility: Oxolife’s non-hormonal oral drug raises embryo implantation rate, pregnancy rates and live birth … [Read more...] about A pill for infertility: Oxolife’s non-hormonal oral drug raises embryo implantation rate, pregnancy rates and live birth rate in women undergoing IVF and ICSI, data being presented at ESHRE shows
OXOART2, selected as one of the most exciting pieces of research presented at ESHRE 40th annual meeting celebrated in Amsterdam
Novel treatment improves embryo implantation and live birth rates in infertile women undergoing IVF and ICSI New … [Read more...] about OXOART2, selected as one of the most exciting pieces of research presented at ESHRE 40th annual meeting celebrated in Amsterdam